Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析

◆英語タイトル:Karolinska Development AB (KDEV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDFS204645FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up’s and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care products and orphan drugs for patients suffering from life-threatening diseases in the areas of oncology, infections and wound healing, inflammation, cardiovascular disease, and women’s health. Its portfolio icompanies include Aprea Therapeutics AB, Dilafor AB, Forendo Pharma Oy, OssDsign AB, Modus Therapeutics AB, and others. It serves researchers, patients and investors. Karolinska Development is headquartered in Solna, Sweden.

Karolinska Development AB Key Recent Developments

Mar 02,2021: Karolinska Development’s portfolio company OssDsign announces a fully guaranteed rights issue and launches new corporate strategy
Mar 01,2021: Karolinska Development appoints Per Aniansson as CFO and Investment Director
Feb 19,2021: Karolinska Development’s Extraordinary General Meeting 2021
Nov 11,2020: Karolinska Development: Interim report – January-September 2020
Sep 08,2020: Karolinska Development’s CFO is leaving the company

This comprehensive SWOT profile of Karolinska Development AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Karolinska Development AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Karolinska Development AB – Key Information
Karolinska Development AB – Overview
Karolinska Development AB – Key Employees
Karolinska Development AB – Key Employee Biographies
Karolinska Development AB – Key Operational Heads
Karolinska Development AB – Major Products and Services
Karolinska Development AB – History
Karolinska Development AB – Company Statement
Karolinska Development AB – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Karolinska Development AB – Business Description
Karolinska Development AB – Corporate Strategy
Karolinska Development AB – SWOT Analysis
SWOT Analysis – Overview
Karolinska Development AB – Strengths
Karolinska Development AB – Weaknesses
Karolinska Development AB – Opportunities
Karolinska Development AB – Threats
Karolinska Development AB – Key Competitors

Section 3 – Company Financial Performance Charts

Karolinska Development AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Karolinska Development AB, Key Information
Karolinska Development AB, Key Ratios
Karolinska Development AB, Share Data
Karolinska Development AB, Major Products and Services
Karolinska Development AB, History
Karolinska Development AB, Key Employees
Karolinska Development AB, Key Employee Biographies
Karolinska Development AB, Key Operational Heads
Karolinska Development AB, Other Locations
Karolinska Development AB, Subsidiaries

Karolinska Development AB, Key Competitors
Karolinska Development AB, SWOT Analysis
Karolinska Development AB, Ratios based on current share price
Karolinska Development AB, Annual Ratios
Karolinska Development AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UNITIKA LTD.:企業の戦略・SWOT・財務分析
    UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report Summary UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cenovus Energy Inc (CVE):企業の財務・戦略的SWOT分析
    Cenovus Energy Inc (CVE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Condor Petroleum Inc (CPI)-石油・ガス分野:企業M&A・提携分析
    Summary Condor Petroleum Inc. (Condor) is an independent upstream oil and gas company. The company through its subsidiaries, acquires, explores, produces and markets oil and gas. It has operational presence in Kazakhstan and Turkey. The company operates on the Pre-Caspian basin, a prolific region th …
  • Hofseth Biocare ASA:企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sunovion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunovion Pharmaceuticals Inc (Sunovion), a subsidiary of Sumitomo Dainippon Pharma Co Ltd, is a research-based pharmaceutical company. It discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and respiratory disorders. Its product p …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Daily Mail and General Trust plc:企業のM&A・事業提携・投資動向
    Daily Mail and General Trust plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daily Mail and General Trust plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • American Airlines Group Inc.:企業の戦略・SWOT・財務情報
    American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report Summary American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lantheus Medical Imaging Inc:企業の戦略的SWOT分析
    Lantheus Medical Imaging Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Acceleron Pharma Inc (XLRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Acceleron Pharma Inc (Acceleron Pharma) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics to treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodys …
  • CollPlant Ltd (CLGN):医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Holdings Ltd (CollPlant) is a regenerative medicine company that carries out development and commercialization of tissue repair products. The company offers orthobiologics, wound care, and pipeline products. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant …
  • TechnipFMC Plc (FTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TechnipFMC plc (TechnipFMC) is a provider of oil and gas technologies, systems and services. The company focuses on subsea, surface technologies, onshore and offshore projects. Its portfolio of subsea services include drilling, asset management, installation of oil and gas field, remotely op …
  • Prismic Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a pharmaceutical company that provides research and development of prescription drugs which has unique safety profiles. The company develops drugs for inflammatory diseases and oxidative stress disorders. It pipeline products are used …
  • Yamana Gold Inc.
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • IntegraGen SA (ALINT):企業の財務・戦略的SWOT分析
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • Direct Energie SA (DIREN):企業の財務・戦略的SWOT分析
    Summary Direct Energie SA (Direct Energie), formerly Poweo Direct Energie SA, a subsidiary of Total SA, is a power company that generates and distributes electricity and natural gas. The company's services include construction of combined cycle gas, electrical repair services, technical services, an …
  • Advanced Digital Broadcast SA:企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Proteome Sciences Plc (PRM):企業の財務・戦略的SWOT分析
    Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fomento de Construcciones y Contratas SA (FCC):電力:M&Aディール及び事業提携情報
    Summary Fomento de Construcciones y Contratas SA (FCC) is a citizen services company. It provides services in environmental, water, and infrastructure development sectors. The company manages and treats domestic and industrial waste; provides integrated water management services; and designs, develo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆